Track the GlucoTrack, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €3.3m. The latest transaction was disclosed on 7 October 2025 (Attribution). Among the most active insiders: Balo Andrew K. The full history is accessible without an account.
17
Insider Decl.
n/a
Thresholds
€215,880
1 ops.
Buy Volume
n/a
n/a
Sell Volume
30Σ signal
Buys €215,880n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
182,539.6 shares@ US$1.26100.0% of flowCommon StockSEC:0001493152-24-015833:0
Canonical exit: 21 Jul 2024 (T+90)
17 of 17 declarations
Acerca de GlucoTrack, Inc.
GlucoTrack, Inc. es una empresa centrada en el desarrollo de tecnologías de monitorización de glucosa en sangre. Se especializa en soluciones no invasivas para personas con diabetes.